FibroGen (FGEN) Tops Q2 EPS by 31c

FibroGen (NASDAQ: FGEN) reported Q2 EPS of ($0.28), $0.31 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $43.95 million versus the consensus estimate of $27.74 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Prabhudas Lilladher Starts Blue Star Limited (BLSTR:IN) at Buy (1)
• Burning Rock founder buys $618K in company ADS shares